DELMAR SMITH: Open Payments
NPI 1336110980 · MOUNTAIN HOME, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$302 in 13 payments from 8 companies in 2025. Trend: 2023 $105 · 2024 $373 · 2025 $302
Food & beverage: $302
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $99 |
| Exact Sciences Corporation | 2 | $92 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Novo Nordisk Inc | 1 | $23 |
| ABBVIE INC. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| Medtronic, Inc. | 1 | $15 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: CAPLYTA, The Cologuard Plus Collection Kit, LEQVIO, Rybelsus, QULIPTA, XIFAXAN, Cologuard Collection Kit, INCEPTIV.
Industry payments across ID — which companies pay providers there.
